BioHealth News Archive
Janssen Inc. and Johnson & Johnson Innovation establish research collaboration with the University of Toronto – MarketWatch
Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease Janssen Inc. (Janssen) today announced it has signed an agreement, facilitated by the Johnson…
Read MoreWhat Is Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s Disease? – MIT Technology Review
It’s no surprise that social-media campaigns can raise awareness of an issue, but the ALS Ice Bucket Challenge may be unprecedented in its impact…
Read MoreBioFund passes $2 million in loans for startups in Southeast Louisiana – NOLA.com
The low-interest loan program called the BioFund has issued more than $2 million in loans to 12 businesses that account for 135 jobs in Southeast…
Read MoreWhere Is the Smart Venture Capital Money Going in Digital Health / Health IT?
According to CB Insights data, funding to digital health/health IT companies has already topped $2.2B in the first half of 2014. With the space…
Read MoreCapital Buzz: Entrepreneurial brothers create venture capital fund – The Washington Post
Two Washington entrepreneurs with a history of building successful companies have teamed with a local businessman to start a venture capital fund focused on…
Read MoreEmergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine – Seeking Alpha
Emergent BioSolutions Inc. (EBS) announced today that it has signed a contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of…
Read MoreRoche’s rheumatoid arthritis drug wins EU approval for extended use | Reuters
Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid…
Read MoreMedImmune BioNetworking Event for Post-Docs & Professional
WHEN: Thursday, Sept 25th, 2014 From 3:00 to 5:00 PM WHERE: One MedImmune Way Gaithersburg MD 20878 BioBuzz Double Helix Sponsor MedImmune is hosting…
Read MoreMIMETAS receives 1.7 million dollar pharma funding for kidney-on-a-chip nephrotoxicity model
MIMETAS, in a consortium with Radboudumc and FHNW, has received 1.6 million USD funding for development of a kidney-on-a-chip for toxicological applications. A panel…
Read MoreRaise Capital with Angel Venture Forum D.C.
This Monday September 1st marked the beginning of when investors with Angel Venture Forum D.C. started looking at submissions from companies for the Nov.…
Read MoreUC Berkeley students launch health tech incubator – The Daily Californian
A group of UC Berkeley students launched what they call the first-ever student-run health tech incubator Thursday at the office of Downtown Berkeley’s Skydeck,…
Read MoreF.D.A. Allows First Use of a Novel Cancer Drug – NYTimes.com
The Food and Drug Administration on Thursday approved the first of an eagerly awaited new class of cancer drugs that unleashes the body’s immune…
Read MoreGlaxoSmithKline Leads a Surprising Push for Data Sharing | MIT Technology Review
When British pharmaceutical giant GlaxoSmithKline announced in October 2012 that it planned to make detailed data from its clinical trials widely available to researchers…
Read MoreJob Opportunity: Director, Office of Translational Alliances and Coordination – NHLBI
The National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) in Bethesda, Maryland is seeking a dynamic, innovative and accomplished biomedical/biotechnology…
Read MoreBusiness Awards Dinner – Montgomery County Chamber of Commerce
SAVE THE DATE: THURSDAY, NOVEMBER 20, 2014 The MCCC Business Awards Dinner Committee and Chair of the Board Lisa Cines, CPA of Dixon Hughes…
Read More